Report: China’s Innovent prices domestic PD-1 inhibitor at smaller discount than Junshi

Innovent priced its anti-PD-1 mAb Tyvyt in China at a discount compared with the China price of Keytruda, but a premium to the price of fellow domestic PD-1

Read the full 283 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE